Document Detail


Alternative approaches to cervical cancer screening for developing countries.
MedLine Citation:
PMID:  22385539     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Cervical cancer remains the most common cancer among women living in developing countries, largely because of the failure either to initiate or sustain effective cervical-cancer screening programmes. This potentially preventable and curable cancer continues to cause high mortality among relatively young women residing in low-resource countries. Cytology as a screening test, linked with a robust healthcare infrastructure, has significantly affected cervical cancer prevention in countries that have had sufficient resources to establish and sustain well-conducted programmes. The failure to establish such programmes has stimulated a large body of research into alternative screening tests and approaches to cervical-cancer prevention. Two of the most recent research methods have been visual inspection with acetic acid and molecular testing for high-risk types of human papillomavirus deoxyribonucleic acid. Visual inspection with acetic acid has shown a great deal of promise in cross-sectional studies; however, in randomised-controlled trials, it has been shown to be significantly less effective in reducing cervical cancer or its precursors. The development of point-of-care human papillomavirus or other highly sensitive tests for the prevention of cervical cancer is imperative. It has also been clearly shown that linking testing or screening to treatment (so-called 'screen and treat') without the intervention of colposcopy or the need for sophisticated laboratories may potentially prevent cervical cancer in large numbers of women.
Authors:
Thomas C Wright; Louise Kuhn
Related Documents :
24051039 - Polymorphisms in genes coding for hsp-70 are associated with gastric cancer and duodena...
24403289 - Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortalit...
23732029 - Cervical cancer prevention: new guidelines in the united states and new opportunities f...
22348399 - Evaluating the effectiveness of gp endorsement on increasing participation in the nhs b...
24453519 - Fertility preservation in gynecological cancers.
24616329 - Implementing family health history risk stratification in primary care: impact of guide...
3773619 - Homograft (allograft) tympanoplasty update.
23087289 - Management of trismus following radiation therapy by cost-effective approach.
8186079 - Academic detailing: a model for in-office cme.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Best practice & research. Clinical obstetrics & gynaecology     Volume:  26     ISSN:  1532-1932     ISO Abbreviation:  Best Pract Res Clin Obstet Gynaecol     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101121582     Medline TA:  Best Pract Res Clin Obstet Gynaecol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  197-208     Citation Subset:  IM    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Affiliation:
Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16-404, P&S Building, 630 W. 168th Street, New York, NY 10032, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Photoswitchable nanoparticles for triggered tissue penetration and drug delivery.
Next Document:  Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in ...